FUL · Insider Trading
H.B. Fuller Company
Every open-market purchase and sale reported by FUL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-12 | Nathan D. Weaver | Exec VP, Business Transform. | Sell | −1,200 | −$60.51K |
| 2026-11-09 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-11-09 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-10-26 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-10-26 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-10-19 | Muhammad Shahbaz Malik | Senior VP, BAS | Buy | +478 | +$25.00K |
| 2026-10-13 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-10-13 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-10-08 | R Jeffrey Bailly | Director | Buy | +10,000 | +$500.00K |
| 2026-10-06 | Gregory O. Ogunsanya | Sr. VP, GC and Corp Secretary | MIXED | +472 | +$23.69K |
| 2026-10-02 | R Jeffrey Bailly | Director | A | +1,300 deriv. | — |
| 2026-10-01 | Michael J Happe | Director | Buy | +2,000 | +$99.25K |
| 2026-10-01 | Celine Christine Martin | Director | Buy | +464 | +$23.00K |
| 2026-09-30 | Charles T Lauber | Director | Buy | +2,005 | +$99.98K |
| 2026-09-30 | Srilata Zaheer | Director | Buy | +2,040 | +$100.12K |
| 2026-09-30 | Daniel L Florness | Director | Buy | +2,030 | +$100.16K |
| 2026-09-30 | Trangsrud Teresa J Rasmussen | Director | Buy | +2,042 | +$99.98K |
| 2026-09-30 | Thomas W Handley | Director | Buy | +2,000 | +$98.82K |
| 2026-09-28 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-09-28 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-09-14 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-09-14 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-09-01 | Daniel L Florness | Director | A | — | — |
| 2026-09-01 | Ruth Kimmelshue | Director | A | — | — |
| 2026-09-01 | Michael J Happe | Director | A | — | — |
| 2026-09-01 | Trangsrud Teresa J Rasmussen | Director | A | — | — |
| 2026-09-01 | Thomas W Handley | Director | A | — | — |
| 2026-09-01 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-09-01 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-08-18 | Trangsrud Teresa J Rasmussen | Director | Buy | +1,000 | +$65.83K |
| 2026-08-18 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-08-18 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-08-12 | Nathan D. Weaver | Exec VP, Business Transform. | MIXED | — | −$98.42K |
| 2026-08-03 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-08-03 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-07-20 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-07-20 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-07-16 | Charles T Lauber | Director | A | — | — |
| 2026-07-16 | Michael J Happe | Director | A | — | — |
| 2026-07-16 | Celine Christine Martin | Director | A | +2,894 deriv. | — |
| 2026-07-16 | Srilata Zaheer | Director | A | — | — |
| 2026-07-16 | Trangsrud Teresa J Rasmussen | Director | A | — | — |
| 2026-07-16 | Ruth Kimmelshue | Director | A | — | — |
| 2026-07-16 | Daniel L Florness | Director | A | — | — |
| 2026-07-16 | Thomas W Handley | Director | A | — | — |
| 2026-07-10 | Joao Magalhaes | Sr. VP, Engineering Adhesives | M | +1,658 | +$83.07K |
| 2026-07-07 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-07-07 | John J Corkrean | Executive VP and CFO | A | — | — |
| 2026-06-23 | Heather Campe | Sr. VP, International Growth | A | — | — |
| 2026-06-23 | John J Corkrean | Executive VP and CFO | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Lee R Mitau | Director | 85,343 | $4.08M |
| John J Corkrean | Executive VP and CFO | 59,508 | $2.84M |
| Celeste Beeks Mastin | President and CEO | 41,543 | $1.99M |
| Zhiwei Cai | Executive Vice President, EA | 38,409 | $1.84M |
| Heather Campe | Sr. VP, International Growth | 24,653 | $1.18M |
| Robert J Martsching | VP, Corporate Controller | 16,033 | $766.39K |
| Muhammad Shahbaz Malik | Senior VP, BAS | 14,175 | $677.60K |
| Nathan D. Weaver | Exec VP, Business Transform. | 10,735 | $513.18K |
| R Jeffrey Bailly | Director | 10,000 | $478.00K |
| Gregory O. Ogunsanya | Sr. VP, GC and Corp Secretary | 6,742 | $322.27K |
| James J. East | Executive Vice President, HHC | 5,964 | $285.09K |
| Joao Magalhaes | Sr. VP, Engineering Adhesives | 5,523 | $264.00K |
| Trangsrud Teresa J Rasmussen | Director | 5,444 | $260.25K |
| Srilata Zaheer | Director | 3,386 | $161.85K |
| Daniel L Florness | Director | 3,381 | $161.61K |
| Charles T Lauber | Director | 3,356 | $160.42K |
| Thomas W Handley | Director | 3,347 | $159.99K |
| Michael J Happe | Director | 3,343 | $159.80K |
| Xinyu Du | Sr. VP, Global R&D | 3,081 | $147.27K |
| Ruth Kimmelshue | Director | 1,351 | $64.58K |
| Laura J Lorenz | Sr. VP, HR & Communication | 1,036 | $49.52K |
| Celine Christine Martin | Director | 464 | $22.21K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the FUL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.